Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,335,859
  • Shares Outstanding, K 141,798
  • Annual Sales, $ 810,460 K
  • Annual Income, $ -28,600 K
  • 60-Month Beta 0.78
  • Price/Sales 6.42
  • Price/Cash Flow 389.30
  • Price/Book 7.32
Trade IONS with:

Options Overview Details

View History
  • Implied Volatility 60.45% ( +10.66%)
  • Historical Volatility 68.53%
  • IV Percentile 78%
  • IV Rank 48.35%
  • IV High 83.90% on 01/10/22
  • IV Low 38.48% on 08/18/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 1,879
  • Volume Avg (30-Day) 237
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 7,906
  • Open Int (30-Day) 9,574

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.62
  • Number of Estimates 9
  • High Estimate -0.31
  • Low Estimate -0.77
  • Prior Year -0.57
  • Growth Rate Est. (year over year) -8.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.46 +19.61%
on 05/09/22
40.42 -6.90%
on 04/28/22
-2.23 (-5.59%)
since 04/27/22
3-Month
31.32 +20.15%
on 02/28/22
44.42 -15.29%
on 04/21/22
+5.85 (+18.41%)
since 02/25/22
52-Week
25.04 +50.28%
on 12/02/21
44.42 -15.29%
on 04/21/22
+0.78 (+2.12%)
since 05/27/21

Most Recent Stories

More News
Ionis (IONS) Q1 Earnings & Sales Beat Estimates, Stock Rises

Ionis (IONS) incurs a narrower-than-expected loss in Q1. Its sales also come ahead of estimates. Stock moves up in response to the results.

AZN : 67.40 (+1.05%)
NVS : 91.46 (+0.22%)
BIIB : 206.20 (+0.97%)
IONS : 37.63 (+2.67%)
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 32.35% and 9.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IONS : 37.63 (+2.67%)
NKTR : 3.54 (+2.31%)
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?

Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IONS : 37.63 (+2.67%)
Biogen (BIIB), Ionis to End Early-Stage ALS Candidate Development

Biogen (BIIB) & partner Ionis (IONS) to terminate the development of their antisense ALS candidate, as the drug failed to show any clinical benefit in an early-stage study for C9orf72-associated ALS.

BIIB : 206.20 (+0.97%)
COLL : 15.94 (+2.57%)
IONS : 37.63 (+2.67%)
APLS : 42.61 (+1.57%)
Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis

BIIB078, an investigational antisense oligonucleotide for C9orf72-associated amyotrophic lateral sclerosis (ALS), did not show clinical benefit; clinical...

BIIB : 206.20 (+0.97%)
IONS : 37.63 (+2.67%)
Ionis (IONS) Q4 Earnings & Revenues Beat Estimates, Stock Up

Teaser: Ionis (IONS) beats Q4 earnings and sales estimates. Stock rises.

AZN : 67.40 (+1.05%)
BIIB : 206.20 (+0.97%)
PFE : 53.91 (-0.15%)
IONS : 37.63 (+2.67%)
Company News for Feb 25, 2022

Companies in The News Are: AEP,ATHM,IONS,DISH

AEP : 103.57 (+0.97%)
DISH : 22.30 (+1.36%)
ATHM : 34.01 (+2.81%)
IONS : 37.63 (+2.67%)
Ionis Pharmaceuticals (IONS) Q4 Earnings and Revenues Beat Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 76.25% and 30.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?...

IONS : 37.63 (+2.67%)
INFI : 0.7500 (+24.36%)
Ionis Pharmaceuticals (IONS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IONS : 37.63 (+2.67%)
2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul

These funds can take some of the risks out of these exciting but sometimes dangerous sectors.

SBIO : 26.39 (+1.79%)
BLOK : 22.71 (+2.57%)
IONS : 37.63 (+2.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

See More

Key Turning Points

3rd Resistance Point 39.42
2nd Resistance Point 38.54
1st Resistance Point 38.08
Last Price 37.63
1st Support Level 36.74
2nd Support Level 35.86
3rd Support Level 35.40

See More

52-Week High 44.42
Last Price 37.63
Fibonacci 61.8% 37.02
Fibonacci 50% 34.73
Fibonacci 38.2% 32.44
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar